Press-release for stocks for eli lilly and company

Prices are updated after-hours

Lilly Announces Details of Presentations at 2021 American Association for Cancer Research (AACR)
Published: 2021-03-10 (Crawled : 22:04) - prnewswire.com
LLY | News | $733.3 -1.66% 1.4M

| 259.72% | O: 0.52% H: 0.36% C: -0.63%
cancer research

| -87.04% | O: 1.27% H: 5.99% C: 3.83%
LLY | News | $733.3 -1.66% 1.4M

| 258.57% | O: 0.38% H: 0.56% C: -0.69%
covid phase 3 trial

Oncorus Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Highlights
Published: 2021-03-10 (Crawled : 12:40) - biospace.com/
MRK | $127.345 0.37% 4.6M

| 71.14% | O: 0.84% H: 0.63% C: 0.0%
LLY | News | $733.3 -1.66% 1.4M

| 258.57% | O: 0.38% H: 0.56% C: -0.69%
ONCR | $0.126 -75.95% 140K

| -99.12% | O: 0.07% H: 5.6% C: 3.98%
financial results results

Lilly's bamlanivimab and etesevimab together reduced hospitalizations and death in Phase 3 trial for early COVID-19
Published: 2021-03-10 (Crawled : 12:39) - biospace.com/
LLY | News | $733.3 -1.66% 1.4M

| 258.57% | O: 0.38% H: 0.56% C: -0.69%
covid phase 3 trial

58%

42%

CSSE 4 | $0.3831 151.54% 190M

CZOO | $11.04 121.24% 11M

LICN | $0.9107 62.63% 14M

BOF | $1.87 59.83% 100M

AMST | $3.18 59.0% 67M

SKIL 4 | $8.72 52.72% 410K

MTC | $3.31 47.77% 7.7M

MULN | News | $3.915 43.41% 12M

WIMI | $1.04 43.37% 17M

RILY | $29.755 36.99% 12M

Save your searches and get alerts when important news are released.